athenahealth Company Profile (NASDAQ:ATHN)

About athenahealth

athenahealth logoathenahealth, Inc. is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support. Through these services, the Company connects healthcare information and processes, and drives results for approximately 75,000 healthcare providers. The Company has developed various cloud-based services. Its services include athenaCollector for revenue cycle and practice management; athenaClinicals for electronic health records; athenaCommunicator for patient engagement; athenaCoordinator for order transmission; athenaCoordinator Enterprise for patient access, care coordination, and order transmission; athenaCommunicator Enterprise for population health management, and Epocrates for clinical decision support.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: ATHN
  • CUSIP: 04685W10
Key Metrics:
  • Previous Close: $116.94
  • 50 Day Moving Average: $118.16
  • 200 Day Moving Average: $115.04
  • 52-Week Range: $90.11 - $143.85
  • Trailing P/E Ratio: 228.77
  • Foreward P/E Ratio: 39.26
  • P/E Growth: 2.04
  • Market Cap: $4.70B
  • Outstanding Shares: 39,518,000
  • Beta: 1.77
  • Net Margins: 1.94%
  • Return on Equity: 6.41%
  • Return on Assets: 3.31%
  • Debt-to-Equity Ratio: 0.43%
  • Current Ratio: 1.73%
  • Quick Ratio: 1.73%
Additional Links:
Companies Related to athenahealth:

Analyst Ratings

Consensus Ratings for athenahealth (NASDAQ:ATHN) (?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $132.82 (11.65% upside)

Analysts' Ratings History for athenahealth (NASDAQ:ATHN)
DateFirmActionRatingPrice TargetDetails
2/6/2017KeyCorpSet Price TargetBuy$140.00View Rating Details
2/7/2017Leerink SwannSet Price TargetHold$110.00View Rating Details
2/7/2017Piper Jaffray CompaniesReiterated RatingOutperform$162.00 -> $160.00View Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00View Rating Details
2/6/2017Stifel NicolausLower Price TargetHold$125.00 -> $116.00View Rating Details
2/6/2017Canaccord GenuityReiterated RatingHold$112.00View Rating Details
2/6/2017Dougherty & CoLower Price TargetBuy$150.00 -> $143.00View Rating Details
2/4/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$142.00View Rating Details
2/3/2017Robert W. BairdSet Price TargetBuy$155.00View Rating Details
1/31/2017Cantor FitzgeraldReiterated RatingOutperform$135.00View Rating Details
1/15/2017Jefferies Group LLCSet Price TargetSell$95.00View Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00View Rating Details
1/3/2017RBC Capital MarketsInitiated CoverageOutperformView Rating Details
1/3/2017Wells Fargo & CompanyInitiated CoverageOutperformView Rating Details
10/28/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$128.00 -> $111.00View Rating Details
10/26/2016Morgan StanleyDowngradeOverweight -> Equal Weight$153.00 -> $117.00View Rating Details
10/10/2016Evercore ISIUpgradeHold -> Buy$152.00View Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00View Rating Details
7/22/2016Deutsche Bank AGDowngradeBuy -> Hold$165.00 -> $147.00View Rating Details
2/8/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$155.00 -> $149.00View Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00View Rating Details
2/5/2016Cowen and CompanyReiterated RatingOutperform$174.00 -> $162.00View Rating Details
12/11/2015Barclays PLCReiterated RatingSell$110.00View Rating Details
10/26/2015Royal Bank Of CanadaBoost Price TargetUnderperform$80.00 -> $105.00View Rating Details
10/23/2015Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$160.00View Rating Details
10/21/2015Avondale PartnersInitiated CoverageMarket Perform$175.00View Rating Details
6/18/2015StephensInitiated CoverageOutperform$168.00View Rating Details
(Data available from 2/21/2015 forward)


Earnings History for athenahealth (NASDAQ:ATHN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$276.70 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115$0.14$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114$0.17$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for athenahealth (NASDAQ:ATHN)
Current Year EPS Consensus Estimate: $2.47 EPS
Next Year EPS Consensus Estimate: $3.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.04)$0.04$0.00
Q2 20161$0.15$0.15$0.15
Q3 20162$0.17$0.21$0.19
Q4 20163$0.29$0.34$0.32
Q1 20172$0.17$0.28$0.23
Q2 20172$0.25$0.34$0.30
Q3 20172$0.36$0.37$0.37
Q4 20172$0.35$0.50$0.43
(Data provided by Zacks Investment Research)


Dividend History for athenahealth (NASDAQ:ATHN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for athenahealth (NASDAQ:ATHN)
Insider Ownership Percentage: 3.04%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.25View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.00View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.00View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.00View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.00View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.87View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.08View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.00View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.75View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.00View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.00View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.00View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.00View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.00View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.00View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.05View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.00View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.00View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.15View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.00View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.95View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.50View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.27View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.28View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.00View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.20View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.75View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.00View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.90View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.00View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.00View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.00View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.00View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.00View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.22View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.00View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.00View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.00View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.00View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.00View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.00View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.00View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.00View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.00View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.00View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.00View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.00View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.00View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.00View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.00View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.00View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.00View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.00View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.00View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.00View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.00View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.00View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.00View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.00View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.00View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for athenahealth (NASDAQ:ATHN)
DateHeadline logoathenahealth Partners with Specialty Medical Societies to Roll Out Network Medicine Health Campaigns (NASDAQ:ATHN) - February 20 at 8:44 AM logoTranscend Insights and athenahealth Announce Interoperability Partnership (NASDAQ:ATHN) - February 16 at 8:46 PM
News IconChecking the Levels on Shares of athenahealth, Inc. (NASDAQ:ATHN) - BVN (NASDAQ:ATHN) - February 16 at 3:44 PM logoathenahealth’s Health Plan Data Exchange Service Enables Data Exchange Between Providers and Health Plans (NASDAQ:ATHN) - February 16 at 8:34 AM
News IconPeeling Back The Layers on athenahealth, Inc. (NASDAQ:ATHN): Analysts & Street Weigh In - Winfield Review (NASDAQ:ATHN) - February 15 at 2:22 AM logoathenahealth Offers Network-Driven Performance Assessments at HIMSS17 - GlobeNewswire (press release) (NASDAQ:ATHN) - February 15 at 2:22 AM
News IconCommit To Purchase Athenahealth At $70, Earn 7.7% Using Options (NASDAQ:ATHN) - February 14 at 4:20 PM logoathenahealth Offers Network-Driven Performance Assessments at HIMSS17 (NASDAQ:ATHN) - February 14 at 4:20 PM logoETFs with exposure to athenahealth, Inc. : February 14, 2017 (NASDAQ:ATHN) - February 14 at 4:20 PM
News IconMarket Scanner: Checking the Levels for athenahealth, Inc. (NASDAQ:ATHN) - The Standard (NASDAQ:ATHN) - February 9 at 3:48 PM
News IconStock Sheet: Reviewing the Levels for athenahealth, Inc. (NASDAQ:ATHN) - Baldwin Journal (NASDAQ:ATHN) - February 9 at 1:19 AM logoathenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : February 8, 2017 (NASDAQ:ATHN) - February 8 at 3:16 PM logoathenahealth, Inc. :ATHN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 (NASDAQ:ATHN) - February 8 at 3:16 PM logoAnalysts says athenahealth's growth 2017 goals may be too high (NASDAQ:ATHN) - February 8 at 3:16 PM logoATHENAHEALTH INC Financials (NASDAQ:ATHN) - February 8 at 3:16 PM
News IconSADIF Analytics releases new summary due diligence report for athenahealth Inc ($ATHN). (NASDAQ:ATHN) - February 7 at 4:37 PM logoAnalyst Activity – Berenberg Bank Initiates Coverage On athenahealth (NASDAQ:ATHN) With a Buy (NASDAQ:ATHN) - February 7 at 4:37 PM logoathenahealth Upgraded: What You Need to Know (NASDAQ:ATHN) - February 7 at 2:13 PM
News IconStock Price of athenahealth, Inc. (ATHN) Decreases -12.78% - Morning Outlook (NASDAQ:ATHN) - February 6 at 3:42 PM
News IconAnalyst's Proposition on Legg Mason, Inc. (LM), athenahealth, Inc. (ATHN) - The USA Commerce (NASDAQ:ATHN) - February 6 at 3:42 PM
News IconThe Technical Case for and Against athenahealth, Inc. (ATHN) - The USA Commerce (NASDAQ:ATHN) - February 6 at 3:42 PM logoathenahealth, Inc. :ATHN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017 (NASDAQ:ATHN) - February 6 at 3:42 PM logoAthenahealth 4Q EPS Beats Street Estimates (ATHN) - Investopedia (NASDAQ:ATHN) - February 4 at 8:45 PM logo5 Best Stocks for High-Risk Investors (NASDAQ:ATHN) - February 4 at 3:45 PM logoAthenahealth (ATHN) Shares Cross Below 200 DMA (NASDAQ:ATHN) - February 4 at 1:52 AM logoAthenahealth Inc. (ATHN) Is Sinking After Q4 Report (NASDAQ:ATHN) - February 4 at 1:52 AM logoathenahealth (ATHN) Q4 2016 Results - Earnings Call Transcript (NASDAQ:ATHN) - February 4 at 1:52 AM logoathenahealth Inc Earnings Call scheduled for 8:00 am ET today (NASDAQ:ATHN) - February 4 at 1:52 AM logoEdited Transcript of ATHN earnings conference call or presentation 3-Feb-17 1:00pm GMT (NASDAQ:ATHN) - February 4 at 1:52 AM logoAthenahealth Inc. (ATHN) Is Sinking After Q4 Report - Nasdaq (NASDAQ:ATHN) - February 3 at 3:49 PM logoAthenahealth 4Q Earnings Beats Street (NASDAQ:ATHN) - February 3 at 3:49 PM logoMild winter hurts Athenahealth revenue, shares slide (NASDAQ:ATHN) - February 3 at 3:49 PM logoWhy Shares of athenahealth, Inc Fell Today (NASDAQ:ATHN) - February 3 at 1:58 PM logoAthenahealth, Inc. Reports Slowing, but Solid, Growth in Q4 (NASDAQ:ATHN) - February 3 at 10:58 AM logoAthenahealth, Inc. Profit Advances 40% In Q4 (NASDAQ:ATHN) - February 3 at 2:37 AM
News IconAthenahealth (NASDAQ:ATHN) 4Q16 earnings; Beats Street View (NASDAQ:ATHN) - February 3 at 2:37 AM logoathenahealth, Inc. Reports Fourth Quarter and Full Year 2016 Results (NASDAQ:ATHN) - February 3 at 2:37 AM logoAthenahealth Q4 revenue short of the mark; shares ease 8% after hours (NASDAQ:ATHN) - February 2 at 11:57 PM logoathenahealth, Inc. Reports Fourth Quarter and Full Year 2016 Results - GlobeNewswire (press release) (NASDAQ:ATHN) - February 2 at 8:43 PM
News Iconathenahealth Inc (ATHN) Releases Earnings Results, Beats ... - Highland Mirror (NASDAQ:ATHN) - February 2 at 8:43 PM logoAthenahealth beats 4Q profit forecasts (NASDAQ:ATHN) - February 2 at 8:43 PM
News Iconathenahealth, Inc. (NASDAQ:ATHN) expected to move 9% in response to its earnings report - Post Analyst (NASDAQ:ATHN) - February 2 at 3:43 PM logoQ4 2016 athenahealth Inc Earnings Release - After Market Close (NASDAQ:ATHN) - February 2 at 3:43 PM logoDonald Trump's 'birth control effect': IUD implants increase on heels of presidential election (NASDAQ:ATHN) - February 2 at 1:52 AM logoMedical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN (NASDAQ:ATHN) - February 1 at 3:49 PM
News IconTrading Scope: Checking on Shares of athenahealth, Inc. (NASDAQ:ATHN) - The Tribune (NASDAQ:ATHN) - January 30 at 4:45 PM
News IconSell-side is Weighing in on athenahealth, Inc. (NASDAQ:ATHN) Earnings & Targets - Aiken Advocate (NASDAQ:ATHN) - January 27 at 9:54 PM
News IconAnalysts Peering Into Their Crystal Balls, What's the Sentiment on athenahealth, Inc. (NASDAQ:ATHN) - Wall Street Beacon (NASDAQ:ATHN) - January 27 at 2:07 AM
News IconBarton Investment Management Boosts Position by $26510247 in athenahealth Inc (ATHN) - Highland Mirror (NASDAQ:ATHN) - January 25 at 3:47 PM
News IconEarnings in Full Force, Analysts Take Aim at athenahealth, Inc. (NASDAQ:ATHN) - Wall Street Beacon (NASDAQ:ATHN) - January 25 at 3:47 PM


What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2017?

19 brokerages have issued 1-year price targets for athenahealth's shares. Their predictions range from $95.00 to $160.00. On average, they expect athenahealth's share price to reach $132.82 in the next year.

When will athenahealth announce their earnings?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)
  • Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and $135 PT on athenahealth (ATHN). On February 2, ATHN is scheduled to report 4Q16 results. We expect the results to be solid and to reinforce our positive view on the shares. athena has been steadily increasing the number of physicians on its network and we expect this positive trend to continue. Importantly, we also expect to see operating profit and margin expansion in 2017. Additionally, athena's goal is to expand its scope along the healthcare continuum. The company has recently entered the small hospital market, which is ripe for disruption, in our opinion. We believe athena has already made some progress in this market. Given an ongoing shift to value-based reimbursement, athena is investing more in its population health capabilities. We believe the company should see continued progress in its population health efforts, especially as physicians comply with MACRA requirements." (1/31/2017)
  • According to Zacks Investment Research, "We believe that athenahealth’s strong product portfolio, expanding physician base and unique business model will continue to drive the top line. The recognition of athenahealth as an Electronic Health Record (EHR) usability leader is also a significant positive, in our opinion. However, the company's second quarter 2016 results disappointed us, as it missed the Zacks Consenus Estimates on both the lines. The company's guidance also failed to impress us. We believe lack of enterprise-sized deals, winding up of government funded stimulus and increasing competition in the HCIT market are major headwinds, at least in the near term." (8/4/2016)

  • Robert W. Baird analysts commented, "We are currently forecasting Revenue of $833.5MM (0.7% higher than Street consensus of $827.8MM), EBITDA of $190.9MM (3% below Street consensus of $197.3MM) and Non-GAAP EPS of $0.56 (6% below Street consensus of $0.60). Given LNKD’s historical pattern of earnings outperformance and the unexpectedly large scale of last quarter’s guide-down relative to Street expectations for 2016, we expect that LNKD should print a relatively solid quarter, with 1Q16 revenue and EBITDA likely to come in at or above guidance. But beyond printing in-line or better results against what we believe was conservative guidance, we believe investors will want to hear constructive commentary suggesting that recent product initiatives are beginning to bear fruit and that LNKD is not facing building pressure driven by macro hiring slow-downs and/or market saturation of core Talent Solutions offerings." (4/26/2016)

Who owns athenahealth stock?

athenahealth's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), Janus Capital Management LLC (14.52%), Sands Capital Management LLC (6.96%), Artisan Partners Limited Partnership (3.53%), State Street Corp (1.23%) and Arrowpoint Asset Management LLC (1.15%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, James L Mann, John A Kane, Jonathan Bush, Karl Stubelis, Kristi Ann Matus, Robert Cosinuke, Stephen N Kahane and Timothy John O'brien.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including TCW Group Inc., Sands Capital Management LLC, Artisan Partners Limited Partnership, Franklin Resources Inc., State Street Corp, Brown Advisory Inc., AQR Capital Management LLC and First Republic Investment Management Inc.. Company insiders that have sold athenahealth stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Karl Stubelis, Kristi Ann Matus and Timothy John O'brien.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was purchased by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Arrowpoint Asset Management LLC, ARK Investment Management LLC, Allianz Asset Management AG, Friess Associates LLC, A.R.T. Advisors LLC, FMR LLC and Menta Capital LLC.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of athenahealth stock cost?

One share of athenahealth stock can currently be purchased for approximately $118.96.

athenahealth (NASDAQ:ATHN) Chart for Tuesday, February, 21, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Earnings History Chart

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

Dividend History Chart

Dividend Payments by Quarter for athenahealth (NASDAQ:ATHN)

Last Updated on 2/21/2017 by Staff